BM8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 50.68 EUR Market Closed

Market Cap: €9.3B

B	Biomarin Pharmaceutical Inc XBER:BM8	US
E	Elis SA SWB:7EL	FR
T	T-Mobile US Inc F:TM5	US
	ING Groep NV BMV:INGN	NL
F	Fairfax Financial Holdings Ltd BMV:FFHN	CA
C	Compagnie Financiere Richemont SA F:RITN	CH
C	China Telecom Corp Ltd SWB:ZCH	CN
K	Knowledge Atlas Technology JSC Ltd HKEX:2513	CN
W	Wheaton Precious Metals Corp XMUN:SII	CA
B	British American Tobacco PLC LSE:0A76	UK

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

80%

Gross Margin is Increasing

78% > 80%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

4% > 20%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

4% > 2%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.